查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1239490

輸尿管鏡市場：按產品、應用、最終用戶分類：2021-2031 年全球機會分析和行業預測

Ureteroscopy Market By Product, By Application, By End User : Global Opportunity Analysis and Industry Forecast, 2021-2031
出版日期: | 出版商: Allied Market Research | 英文 210 Pages | 商品交期: 2-3個工作天內

價格

2021 年全球輸尿管鏡市場價值 8.0734 億美元，2031 年達到 13.7982 億美元，預計 2022 年至 2031 年的複合年增長率為 5.5%。

輸尿管鏡檢查是一種用於診斷和治療各種泌尿道問題的手術。 將小範圍（如靈活的望遠鏡）引入膀胱和輸尿管。 輸尿管鏡檢查是使用輸尿管鏡檢查上尿路，輸尿管鏡在穿過尿道和膀胱後直接插入輸尿管。 該測試可用於腎結石和上尿路尿路上皮癌等疾病的診斷和治療。 手術通常需要 1 到 3 個小時，並且通常在患者處於全身麻醉下進行。

全球輸尿管鏡檢查市場的增長受到技術進步和需要輸尿管鏡檢查設備的泌尿系統疾病（如腎癌和腎結石）日益流行的推動。這一直是一個主要因素 此外，印度和中國等新興市場不斷增長的醫療需求以及新興市場的增長機會有望在預測期內為輸尿管鏡市場帶來巨大機遇。

然而，與輸尿管鏡相關的高成本阻礙了市場增長。 此外，輸尿管鏡臨床障礙和感染風險是全球輸尿管鏡市場的主要製約因素。 另一方面，由於醫療費用增加以及專科醫院和診所數量的增加，預計中國和印度等國家將為市場增長創造有利可圖的機會。

內容

第一章介紹

第 2 章執行摘要

第 3 章市場概述

  • 市場定義和範圍
  • 主要發現
    • 主要影響因素
    • 主要投資領域
  • 波特的五力分析
    • 供應商的議價能力
    • 買家的議價能力
    • 替代品的威脅很大
    • 新進入者的威脅很大
    • 中等強度的競爭
  • 市場動態
    • 司機
      • 泌尿系統疾病患病率增加
      • 增加泌尿外科手術的數量
      • 對輸尿管鏡的需求不斷增長
    • 約束因素
      • 輸尿管鏡的副作用
      • 數字輸尿管鏡費用高
    • 機會
      • 技術進步的興起
  • 分析 COVID-19 對市場的影響

第 4 章輸尿管鏡檢查市場：按產品分類

  • 概覽
    • 市場規模和預測
  • 輸尿管軟鏡
    • 主要市場趨勢、增長動力和機遇
    • 市場規模和預測：按地區
    • 市場份額分析：按國家/地區分類
  • 半剛性輸尿管鏡
    • 主要市場趨勢、增長動力和機遇
    • 市場規模和預測：按地區
    • 市場份額分析：按國家/地區分類

第 5 章輸尿管鏡市場：按應用

  • 概覽
    • 市場規模和預測
  • 尿石症
    • 主要市場趨勢、增長動力和機遇
    • 市場規模和預測：按地區
    • 市場份額分析：按國家/地區分類
  • 腎癌
    • 主要市場趨勢、增長動力和機遇
    • 市場規模和預測：按地區
    • 市場份額分析：按國家/地區分類
  • 尿路狹窄
    • 主要市場趨勢、增長動力和機遇
    • 市場規模和預測：按地區
    • 市場份額分析：按國家/地區分類
  • 其他
    • 主要市場趨勢、增長動力和機遇
    • 市場規模和預測：按地區
    • 市場份額分析：按國家/地區分類

第 6 章輸尿管鏡檢查市場：按最終用戶分類

  • 概覽
    • 市場規模和預測
  • 醫院
    • 主要市場趨勢、增長動力和機遇
    • 市場規模和預測：按地區
    • 市場份額分析：按國家/地區分類
  • 門診手術中心
    • 主要市場趨勢、增長動力和機遇
    • 市場規模和預測：按地區
    • 市場份額分析：按國家/地區分類
  • 其他
    • 主要市場趨勢、增長動力和機遇
    • 市場規模和預測：按地區
    • 市場份額分析：按國家/地區分類

第 7 章輸尿管鏡市場：按地區

  • 概覽
    • 市場規模和預測：按地區
  • 北美
    • 主要趨勢和機會
    • 市場規模和預測：按產品
    • 市場規模和應用預測
    • 最終用戶的市場規模和預測
    • 市場規模和預測：按國家/地區分類
      • 美國
      • 主要市場趨勢、增長動力和機遇
      • 市場規模和預測：按產品
      • 市場規模和應用預測
      • 最終用戶的市場規模和預測
      • 加拿大
      • 主要市場趨勢、增長動力和機遇
      • 市場規模和預測：按產品
      • 市場規模和應用預測
      • 最終用戶的市場規模和預測
      • 墨西哥
      • 主要市場趨勢、增長動力和機遇
      • 市場規模和預測：按產品
      • 市場規模和應用預測
      • 最終用戶的市場規模和預測
  • 歐洲
    • 主要趨勢和機會
    • 市場規模和預測：按產品
    • 市場規模和應用預測
    • 最終用戶的市場規模和預測
    • 市場規模和預測：按國家/地區分類
      • 德國
      • 主要市場趨勢、增長動力和機遇
      • 市場規模和預測：按產品
      • 市場規模和應用預測
      • 最終用戶的市場規模和預測
      • 法國
      • 主要市場趨勢、增長動力和機遇
      • 市場規模和預測：按產品
      • 市場規模和應用預測
      • 最終用戶的市場規模和預測
      • 英國
      • 主要市場趨勢、增長動力和機遇
      • 市場規模和預測：按產品
      • 市場規模和應用預測
      • 最終用戶的市場規模和預測
      • 意大利
      • 主要市場趨勢、增長動力和機遇
      • 市場規模和預測：按產品
      • 市場規模和應用預測
      • 最終用戶的市場規模和預測
      • 西班牙
      • 主要市場趨勢、增長動力和機遇
      • 市場規模和預測：按產品
      • 市場規模和應用預測
      • 最終用戶的市場規模和預測
      • 其他歐洲
      • 主要市場趨勢、增長動力和機遇
      • 市場規模和預測：按產品
      • 市場規模和應用預測
      • 最終用戶的市場規模和預測
  • 亞太地區
    • 主要趨勢和機會
    • 市場規模和預測：按產品
    • 市場規模和應用預測
    • 最終用戶的市場規模和預測
    • 市場規模和預測：按國家/地區分類
      • 日本
      • 主要市場趨勢、增長動力和機遇
      • 市場規模和預測：按產品
      • 市場規模和應用預測
      • 最終用戶的市場規模和預測
      • 中國
      • 主要市場趨勢、增長動力和機遇
      • 市場規模和預測：按產品
      • 市場規模和應用預測
      • 最終用戶的市場規模和預測
      • 澳大利亞
      • 主要市場趨勢、增長動力和機遇
      • 市場規模和預測：按產品
      • 市場規模和應用預測
      • 最終用戶的市場規模和預測
      • 印度
      • 主要市場趨勢、增長動力和機遇
      • 市場規模和預測：按產品
      • 市場規模和應用預測
      • 最終用戶的市場規模和預測
      • 韓國
      • 主要市場趨勢、增長動力和機遇
      • 市場規模和預測：按產品
      • 市場規模和應用預測
      • 最終用戶的市場規模和預測
      • 其他亞太地區
      • 主要市場趨勢、增長動力和機遇
      • 市場規模和預測：按產品
      • 市場規模和應用預測
      • 最終用戶的市場規模和預測
  • 拉丁美洲/中東/非洲
    • 主要趨勢和機會
    • 市場規模和預測：按產品
    • 市場規模和應用預測
    • 最終用戶的市場規模和預測
    • 市場規模和預測：按國家/地區分類
      • 巴西
      • 主要市場趨勢、增長動力和機遇
      • 市場規模和預測：按產品
      • 市場規模和應用預測
      • 最終用戶的市場規模和預測
      • 沙特阿拉伯
      • 主要市場趨勢、增長動力和機遇
      • 市場規模和預測：按產品
      • 市場規模和應用預測
      • 最終用戶的市場規模和預測
      • 南非
      • 主要市場趨勢、增長動力和機遇
      • 市場規模和預測：按產品
      • 市場規模和應用預測
      • 最終用戶的市場規模和預測
      • 其他拉丁美洲/中東/非洲
      • 主要市場趨勢、增長動力和機遇
      • 市場規模和預測：按產品
      • 市場規模和應用預測
      • 最終用戶的市場規模和預測

第八章競爭格局

  • 介紹
  • 關鍵成功策略
  • 排名前 10 位的玩家產品映射
  • 比賽儀表板
  • 競爭熱圖
  • 2021 年最佳球員排名

第九章公司簡介

  • Advin Health Care
  • Boston Scientific Corporation
  • Cliniva Healthcare
  • KARL STORZ SE & Co. KG
  • Olympus Corporation
  • OTU Medical
  • Hoya Corporation
  • Richard Wolf GmbH
  • STERIS plc
  • Stryker Corporation
Product Code: A11013

The global ureteroscopy market was valued at $807.34 million in 2021, and is projected to reach $1,379.82 million by 2031, registering a CAGR of 5.5% from 2022 to 2031.  

Ureteroscopy is a procedure used to diagnose and treat a wide range of urinary tract issues. A tiny scope (like flexible telescope) is introduced into the bladder and ureter. Ureteroscopy is an examination of the upper urinary tract and performed with an ureteroscope which is inserted directly into the ureter after passing through the urethra and bladder. This procedure is useful in the diagnosis and treatment of disorders such as kidney stones and urothelial carcinoma of the upper urinary tract. The procedure typically takes one to three hours to complete and is usually done while the patient is under general anesthesia.  

The growth of the global ureteroscopy market is majorly driven by rise in technological advancement and increase in prevalence of urological diseases such as kidney cancer and kidney stone that require ureteroscopy devices and are the major factors that boost the market growth. Furthermore, increased medical demands in the developing countries such as India and China and growth opportunities in emerging markets are expected to create immense opportunities for the ureteroscopy market during the forecast period. 

However, the high cost associated with the ureteroscopes hinders the growth of the market. Moreover, clinical barriers for ureteroscopes and risk of infection act as major restraints for the global ureteroscopy market. Conversely, increase in healthcare expenditure and rise in number of specialized hospitals & clinics in countries such as China and India are expected to create lucrative opportunities for the growth of the market. 

The global ureteroscopy market is segmented into product, application, end user, and region. By product, the market is categorized into flexible ureteroscope and semi-rigid ureteroscope. On the basis of application, the market is segregated into urolithiasis, kidney cancer, urinary stricture, and others. According to end user, the market is classified into hospitals, ambulatory surgical centers, and others. Region wise, the market is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA). 

Major key players that operate in the global ureteroscopy market are: Advin Health Care, Boston Scientific Corporation, Cliniva Healthcare, Hoya Corporation, KARL STORZ SE & Co. KG, Olympus Corporation, OTU Medical, Richard Wolf GmbH, STERIS plc, and Stryker Corporation.

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the ureteroscopy market analysis from 2021 to 2031 to identify the prevailing ureteroscopy market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the ureteroscopy market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global ureteroscopy market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By Product

  • Flexible Ureteroscope
  • Semi- Rigid Ureteroscope

By Application

  • Urolithiasis
  • Kidney Cancer
  • Urinary Stricture
  • Others

By End User

  • Hospitals
  • Ambulatory Surgical Centers
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • Australia
    • India
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA

Key Market Players

  • KARL STORZ SE & Co. KG
  • Hoya Corporation
  • Stryker Corporation
  • Boston Scientific Corporation
  • Advin Health Care
  • Cliniva Healthcare
  • Olympus Corporation
  • OTU Medical
  • Richard Wolf GmbH
  • STERIS plc

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report description
  • 1.2. Key market segments
  • 1.3. Key benefits to the stakeholders
  • 1.4. Research Methodology
    • 1.4.1. Primary research
    • 1.4.2. Secondary research
    • 1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO Perspective

CHAPTER 3: MARKET OVERVIEW

  • 3.1. Market definition and scope
  • 3.2. Key findings
    • 3.2.1. Top impacting factors
    • 3.2.2. Top investment pockets
  • 3.3. Porter's five forces analysis
    • 3.3.1. High bargaining power of suppliers
    • 3.3.2. High bargaining power of buyers
    • 3.3.3. High threat of substitutes
    • 3.3.4. High threat of new entrants
    • 3.3.5. Moderate intensity of rivalry
  • 3.4. Market dynamics
    • 3.4.1. Drivers
      • 3.4.1.1. Increase in prevalence of urological diseases
      • 3.4.1.2. Increase in number of urological surgeries
      • 3.4.1.3. Increase in demand for ureteroscopes
    • 3.4.2. Restraints
      • 3.4.2.1. Side effects of ureteroscopes
      • 3.4.2.2. High cost of digital ureteroscopes
    • 3.4.3. Opportunities
      • 3.4.3.1. Rise in technological advancements
  • 3.5. COVID-19 Impact Analysis on the market

CHAPTER 4: URETEROSCOPY MARKET, BY PRODUCT

  • 4.1. Overview
    • 4.1.1. Market size and forecast
  • 4.2. Flexible Ureteroscope
    • 4.2.1. Key market trends, growth factors and opportunities
    • 4.2.2. Market size and forecast, by region
    • 4.2.3. Market share analysis by country
  • 4.3. Semi- Rigid Ureteroscope
    • 4.3.1. Key market trends, growth factors and opportunities
    • 4.3.2. Market size and forecast, by region
    • 4.3.3. Market share analysis by country

CHAPTER 5: URETEROSCOPY MARKET, BY APPLICATION

  • 5.1. Overview
    • 5.1.1. Market size and forecast
  • 5.2. Urolithiasis
    • 5.2.1. Key market trends, growth factors and opportunities
    • 5.2.2. Market size and forecast, by region
    • 5.2.3. Market share analysis by country
  • 5.3. Kidney Cancer
    • 5.3.1. Key market trends, growth factors and opportunities
    • 5.3.2. Market size and forecast, by region
    • 5.3.3. Market share analysis by country
  • 5.4. Urinary Stricture
    • 5.4.1. Key market trends, growth factors and opportunities
    • 5.4.2. Market size and forecast, by region
    • 5.4.3. Market share analysis by country
  • 5.5. Others
    • 5.5.1. Key market trends, growth factors and opportunities
    • 5.5.2. Market size and forecast, by region
    • 5.5.3. Market share analysis by country

CHAPTER 6: URETEROSCOPY MARKET, BY END USER

  • 6.1. Overview
    • 6.1.1. Market size and forecast
  • 6.2. Hospitals
    • 6.2.1. Key market trends, growth factors and opportunities
    • 6.2.2. Market size and forecast, by region
    • 6.2.3. Market share analysis by country
  • 6.3. Ambulatory Surgical Centers
    • 6.3.1. Key market trends, growth factors and opportunities
    • 6.3.2. Market size and forecast, by region
    • 6.3.3. Market share analysis by country
  • 6.4. Others
    • 6.4.1. Key market trends, growth factors and opportunities
    • 6.4.2. Market size and forecast, by region
    • 6.4.3. Market share analysis by country

CHAPTER 7: URETEROSCOPY MARKET, BY REGION

  • 7.1. Overview
    • 7.1.1. Market size and forecast By Region
  • 7.2. North America
    • 7.2.1. Key trends and opportunities
    • 7.2.2. Market size and forecast, by Product
    • 7.2.3. Market size and forecast, by Application
    • 7.2.4. Market size and forecast, by End User
    • 7.2.5. Market size and forecast, by country
      • 7.2.5.1. U.S.
      • 7.2.5.1.1. Key market trends, growth factors and opportunities
      • 7.2.5.1.2. Market size and forecast, by Product
      • 7.2.5.1.3. Market size and forecast, by Application
      • 7.2.5.1.4. Market size and forecast, by End User
      • 7.2.5.2. Canada
      • 7.2.5.2.1. Key market trends, growth factors and opportunities
      • 7.2.5.2.2. Market size and forecast, by Product
      • 7.2.5.2.3. Market size and forecast, by Application
      • 7.2.5.2.4. Market size and forecast, by End User
      • 7.2.5.3. Mexico
      • 7.2.5.3.1. Key market trends, growth factors and opportunities
      • 7.2.5.3.2. Market size and forecast, by Product
      • 7.2.5.3.3. Market size and forecast, by Application
      • 7.2.5.3.4. Market size and forecast, by End User
  • 7.3. Europe
    • 7.3.1. Key trends and opportunities
    • 7.3.2. Market size and forecast, by Product
    • 7.3.3. Market size and forecast, by Application
    • 7.3.4. Market size and forecast, by End User
    • 7.3.5. Market size and forecast, by country
      • 7.3.5.1. Germany
      • 7.3.5.1.1. Key market trends, growth factors and opportunities
      • 7.3.5.1.2. Market size and forecast, by Product
      • 7.3.5.1.3. Market size and forecast, by Application
      • 7.3.5.1.4. Market size and forecast, by End User
      • 7.3.5.2. France
      • 7.3.5.2.1. Key market trends, growth factors and opportunities
      • 7.3.5.2.2. Market size and forecast, by Product
      • 7.3.5.2.3. Market size and forecast, by Application
      • 7.3.5.2.4. Market size and forecast, by End User
      • 7.3.5.3. UK
      • 7.3.5.3.1. Key market trends, growth factors and opportunities
      • 7.3.5.3.2. Market size and forecast, by Product
      • 7.3.5.3.3. Market size and forecast, by Application
      • 7.3.5.3.4. Market size and forecast, by End User
      • 7.3.5.4. Italy
      • 7.3.5.4.1. Key market trends, growth factors and opportunities
      • 7.3.5.4.2. Market size and forecast, by Product
      • 7.3.5.4.3. Market size and forecast, by Application
      • 7.3.5.4.4. Market size and forecast, by End User
      • 7.3.5.5. Spain
      • 7.3.5.5.1. Key market trends, growth factors and opportunities
      • 7.3.5.5.2. Market size and forecast, by Product
      • 7.3.5.5.3. Market size and forecast, by Application
      • 7.3.5.5.4. Market size and forecast, by End User
      • 7.3.5.6. Rest of Europe
      • 7.3.5.6.1. Key market trends, growth factors and opportunities
      • 7.3.5.6.2. Market size and forecast, by Product
      • 7.3.5.6.3. Market size and forecast, by Application
      • 7.3.5.6.4. Market size and forecast, by End User
  • 7.4. Asia-Pacific
    • 7.4.1. Key trends and opportunities
    • 7.4.2. Market size and forecast, by Product
    • 7.4.3. Market size and forecast, by Application
    • 7.4.4. Market size and forecast, by End User
    • 7.4.5. Market size and forecast, by country
      • 7.4.5.1. Japan
      • 7.4.5.1.1. Key market trends, growth factors and opportunities
      • 7.4.5.1.2. Market size and forecast, by Product
      • 7.4.5.1.3. Market size and forecast, by Application
      • 7.4.5.1.4. Market size and forecast, by End User
      • 7.4.5.2. China
      • 7.4.5.2.1. Key market trends, growth factors and opportunities
      • 7.4.5.2.2. Market size and forecast, by Product
      • 7.4.5.2.3. Market size and forecast, by Application
      • 7.4.5.2.4. Market size and forecast, by End User
      • 7.4.5.3. Australia
      • 7.4.5.3.1. Key market trends, growth factors and opportunities
      • 7.4.5.3.2. Market size and forecast, by Product
      • 7.4.5.3.3. Market size and forecast, by Application
      • 7.4.5.3.4. Market size and forecast, by End User
      • 7.4.5.4. India
      • 7.4.5.4.1. Key market trends, growth factors and opportunities
      • 7.4.5.4.2. Market size and forecast, by Product
      • 7.4.5.4.3. Market size and forecast, by Application
      • 7.4.5.4.4. Market size and forecast, by End User
      • 7.4.5.5. South Korea
      • 7.4.5.5.1. Key market trends, growth factors and opportunities
      • 7.4.5.5.2. Market size and forecast, by Product
      • 7.4.5.5.3. Market size and forecast, by Application
      • 7.4.5.5.4. Market size and forecast, by End User
      • 7.4.5.6. Rest of Asia-Pacific
      • 7.4.5.6.1. Key market trends, growth factors and opportunities
      • 7.4.5.6.2. Market size and forecast, by Product
      • 7.4.5.6.3. Market size and forecast, by Application
      • 7.4.5.6.4. Market size and forecast, by End User
  • 7.5. LAMEA
    • 7.5.1. Key trends and opportunities
    • 7.5.2. Market size and forecast, by Product
    • 7.5.3. Market size and forecast, by Application
    • 7.5.4. Market size and forecast, by End User
    • 7.5.5. Market size and forecast, by country
      • 7.5.5.1. Brazil
      • 7.5.5.1.1. Key market trends, growth factors and opportunities
      • 7.5.5.1.2. Market size and forecast, by Product
      • 7.5.5.1.3. Market size and forecast, by Application
      • 7.5.5.1.4. Market size and forecast, by End User
      • 7.5.5.2. Saudi Arabia
      • 7.5.5.2.1. Key market trends, growth factors and opportunities
      • 7.5.5.2.2. Market size and forecast, by Product
      • 7.5.5.2.3. Market size and forecast, by Application
      • 7.5.5.2.4. Market size and forecast, by End User
      • 7.5.5.3. South Africa
      • 7.5.5.3.1. Key market trends, growth factors and opportunities
      • 7.5.5.3.2. Market size and forecast, by Product
      • 7.5.5.3.3. Market size and forecast, by Application
      • 7.5.5.3.4. Market size and forecast, by End User
      • 7.5.5.4. Rest of LAMEA
      • 7.5.5.4.1. Key market trends, growth factors and opportunities
      • 7.5.5.4.2. Market size and forecast, by Product
      • 7.5.5.4.3. Market size and forecast, by Application
      • 7.5.5.4.4. Market size and forecast, by End User

CHAPTER 8: COMPETITIVE LANDSCAPE

  • 8.1. Introduction
  • 8.2. Top winning strategies
  • 8.3. Product Mapping of Top 10 Player
  • 8.4. Competitive Dashboard
  • 8.5. Competitive Heatmap
  • 8.6. Top player positioning, 2021

CHAPTER 9: COMPANY PROFILES

  • 9.1. Advin Health Care
    • 9.1.1. Company overview
    • 9.1.2. Key Executives
    • 9.1.3. Company snapshot
    • 9.1.4. Operating business segments
    • 9.1.5. Product portfolio
  • 9.2. Boston Scientific Corporation
    • 9.2.1. Company overview
    • 9.2.2. Key Executives
    • 9.2.3. Company snapshot
    • 9.2.4. Operating business segments
    • 9.2.5. Product portfolio
    • 9.2.6. Business performance
  • 9.3. Cliniva Healthcare
    • 9.3.1. Company overview
    • 9.3.2. Key Executives
    • 9.3.3. Company snapshot
    • 9.3.4. Operating business segments
    • 9.3.5. Product portfolio
  • 9.4. KARL STORZ SE & Co. KG
    • 9.4.1. Company overview
    • 9.4.2. Key Executives
    • 9.4.3. Company snapshot
    • 9.4.4. Operating business segments
    • 9.4.5. Product portfolio
  • 9.5. Olympus Corporation
    • 9.5.1. Company overview
    • 9.5.2. Key Executives
    • 9.5.3. Company snapshot
    • 9.5.4. Operating business segments
    • 9.5.5. Product portfolio
    • 9.5.6. Business performance
  • 9.6. OTU Medical
    • 9.6.1. Company overview
    • 9.6.2. Key Executives
    • 9.6.3. Company snapshot
    • 9.6.4. Operating business segments
    • 9.6.5. Product portfolio
  • 9.7. Hoya Corporation
    • 9.7.1. Company overview
    • 9.7.2. Key Executives
    • 9.7.3. Company snapshot
    • 9.7.4. Operating business segments
    • 9.7.5. Product portfolio
    • 9.7.6. Business performance
  • 9.8. Richard Wolf GmbH
    • 9.8.1. Company overview
    • 9.8.2. Key Executives
    • 9.8.3. Company snapshot
    • 9.8.4. Operating business segments
    • 9.8.5. Product portfolio
  • 9.9. STERIS plc
    • 9.9.1. Company overview
    • 9.9.2. Key Executives
    • 9.9.3. Company snapshot
    • 9.9.4. Operating business segments
    • 9.9.5. Product portfolio
    • 9.9.6. Business performance
  • 9.10. Stryker Corporation
    • 9.10.1. Company overview
    • 9.10.2. Key Executives
    • 9.10.3. Company snapshot
    • 9.10.4. Operating business segments
    • 9.10.5. Product portfolio
    • 9.10.6. Business performance

LIST OF TABLES

  • TABLE 01. GLOBAL URETEROSCOPY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 02. URETEROSCOPY MARKET FOR FLEXIBLE URETEROSCOPE, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 03. URETEROSCOPY MARKET FOR SEMI- RIGID URETEROSCOPE, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 04. GLOBAL URETEROSCOPY MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 05. URETEROSCOPY MARKET FOR UROLITHIASIS, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 06. URETEROSCOPY MARKET FOR KIDNEY CANCER, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 07. URETEROSCOPY MARKET FOR URINARY STRICTURE, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 08. URETEROSCOPY MARKET FOR OTHERS, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 09. GLOBAL URETEROSCOPY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 10. URETEROSCOPY MARKET FOR HOSPITALS, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 11. URETEROSCOPY MARKET FOR AMBULATORY SURGICAL CENTERS, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 12. URETEROSCOPY MARKET FOR OTHERS, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 13. URETEROSCOPY MARKET, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 14. NORTH AMERICA URETEROSCOPY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 15. NORTH AMERICA URETEROSCOPY MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 16. NORTH AMERICA URETEROSCOPY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 17. NORTH AMERICA URETEROSCOPY MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 18. U.S. URETEROSCOPY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 19. U.S. URETEROSCOPY MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 20. U.S. URETEROSCOPY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 21. CANADA URETEROSCOPY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 22. CANADA URETEROSCOPY MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 23. CANADA URETEROSCOPY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 24. MEXICO URETEROSCOPY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 25. MEXICO URETEROSCOPY MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 26. MEXICO URETEROSCOPY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 27. EUROPE URETEROSCOPY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 28. EUROPE URETEROSCOPY MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 29. EUROPE URETEROSCOPY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 30. EUROPE URETEROSCOPY MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 31. GERMANY URETEROSCOPY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 32. GERMANY URETEROSCOPY MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 33. GERMANY URETEROSCOPY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 34. FRANCE URETEROSCOPY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 35. FRANCE URETEROSCOPY MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 36. FRANCE URETEROSCOPY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 37. UK URETEROSCOPY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 38. UK URETEROSCOPY MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 39. UK URETEROSCOPY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 40. ITALY URETEROSCOPY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 41. ITALY URETEROSCOPY MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 42. ITALY URETEROSCOPY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 43. SPAIN URETEROSCOPY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 44. SPAIN URETEROSCOPY MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 45. SPAIN URETEROSCOPY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 46. REST OF EUROPE URETEROSCOPY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 47. REST OF EUROPE URETEROSCOPY MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 48. REST OF EUROPE URETEROSCOPY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 49. ASIA-PACIFIC URETEROSCOPY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 50. ASIA-PACIFIC URETEROSCOPY MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 51. ASIA-PACIFIC URETEROSCOPY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 52. ASIA-PACIFIC URETEROSCOPY MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 53. JAPAN URETEROSCOPY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 54. JAPAN URETEROSCOPY MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 55. JAPAN URETEROSCOPY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 56. CHINA URETEROSCOPY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 57. CHINA URETEROSCOPY MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 58. CHINA URETEROSCOPY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 59. AUSTRALIA URETEROSCOPY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 60. AUSTRALIA URETEROSCOPY MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 61. AUSTRALIA URETEROSCOPY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 62. INDIA URETEROSCOPY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 63. INDIA URETEROSCOPY MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 64. INDIA URETEROSCOPY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 65. SOUTH KOREA URETEROSCOPY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 66. SOUTH KOREA URETEROSCOPY MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 67. SOUTH KOREA URETEROSCOPY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 68. REST OF ASIA-PACIFIC URETEROSCOPY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 69. REST OF ASIA-PACIFIC URETEROSCOPY MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 70. REST OF ASIA-PACIFIC URETEROSCOPY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 71. LAMEA URETEROSCOPY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 72. LAMEA URETEROSCOPY MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 73. LAMEA URETEROSCOPY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 74. LAMEA URETEROSCOPY MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 75. BRAZIL URETEROSCOPY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 76. BRAZIL URETEROSCOPY MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 77. BRAZIL URETEROSCOPY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 78. SAUDI ARABIA URETEROSCOPY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 79. SAUDI ARABIA URETEROSCOPY MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 80. SAUDI ARABIA URETEROSCOPY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 81. SOUTH AFRICA URETEROSCOPY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 82. SOUTH AFRICA URETEROSCOPY MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 83. SOUTH AFRICA URETEROSCOPY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 84. REST OF LAMEA URETEROSCOPY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 85. REST OF LAMEA URETEROSCOPY MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 86. REST OF LAMEA URETEROSCOPY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 87. ADVIN HEALTH CARE: KEY EXECUTIVES
  • TABLE 88. ADVIN HEALTH CARE: COMPANY SNAPSHOT
  • TABLE 89. ADVIN HEALTH CARE: PRODUCT SEGMENTS
  • TABLE 90. ADVIN HEALTH CARE: PRODUCT PORTFOLIO
  • TABLE 91. BOSTON SCIENTIFIC CORPORATION: KEY EXECUTIVES
  • TABLE 92. BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT
  • TABLE 93. BOSTON SCIENTIFIC CORPORATION: PRODUCT SEGMENTS
  • TABLE 94. BOSTON SCIENTIFIC CORPORATION: PRODUCT PORTFOLIO
  • TABLE 95. CLINIVA HEALTHCARE: KEY EXECUTIVES
  • TABLE 96. CLINIVA HEALTHCARE: COMPANY SNAPSHOT
  • TABLE 97. CLINIVA HEALTHCARE: PRODUCT SEGMENTS
  • TABLE 98. CLINIVA HEALTHCARE: PRODUCT PORTFOLIO
  • TABLE 99. KARL STORZ SE & CO. KG: KEY EXECUTIVES
  • TABLE 100. KARL STORZ SE & CO. KG: COMPANY SNAPSHOT
  • TABLE 101. KARL STORZ SE & CO. KG: PRODUCT SEGMENTS
  • TABLE 102. KARL STORZ SE & CO. KG: PRODUCT PORTFOLIO
  • TABLE 103. OLYMPUS CORPORATION: KEY EXECUTIVES
  • TABLE 104. OLYMPUS CORPORATION: COMPANY SNAPSHOT
  • TABLE 105. OLYMPUS CORPORATION: PRODUCT SEGMENTS
  • TABLE 106. OLYMPUS CORPORATION: PRODUCT PORTFOLIO
  • TABLE 107. OTU MEDICAL: KEY EXECUTIVES
  • TABLE 108. OTU MEDICAL: COMPANY SNAPSHOT
  • TABLE 109. OTU MEDICAL: PRODUCT SEGMENTS
  • TABLE 110. OTU MEDICAL: PRODUCT PORTFOLIO
  • TABLE 111. HOYA CORPORATION: KEY EXECUTIVES
  • TABLE 112. HOYA CORPORATION: COMPANY SNAPSHOT
  • TABLE 113. HOYA CORPORATION: PRODUCT SEGMENTS
  • TABLE 114. HOYA CORPORATION: PRODUCT PORTFOLIO
  • TABLE 115. RICHARD WOLF GMBH: KEY EXECUTIVES
  • TABLE 116. RICHARD WOLF GMBH: COMPANY SNAPSHOT
  • TABLE 117. RICHARD WOLF GMBH: PRODUCT SEGMENTS
  • TABLE 118. RICHARD WOLF GMBH: PRODUCT PORTFOLIO
  • TABLE 119. STERIS PLC: KEY EXECUTIVES
  • TABLE 120. STERIS PLC: COMPANY SNAPSHOT
  • TABLE 121. STERIS PLC: PRODUCT SEGMENTS
  • TABLE 122. STERIS PLC: PRODUCT PORTFOLIO
  • TABLE 123. STRYKER CORPORATION: KEY EXECUTIVES
  • TABLE 124. STRYKER CORPORATION: COMPANY SNAPSHOT
  • TABLE 125. STRYKER CORPORATION: PRODUCT SEGMENTS
  • TABLE 126. STRYKER CORPORATION: PRODUCT PORTFOLIO

LIST OF FIGURES

  • FIGURE 01. URETEROSCOPY MARKET, 2021-2031
  • FIGURE 02. SEGMENTATION OF URETEROSCOPY MARKET, 2021-2031
  • FIGURE 03. TOP INVESTMENT POCKETS IN URETEROSCOPY MARKET (2022-2031)
  • FIGURE 04. HIGH BARGAINING POWER OF SUPPLIERS
  • FIGURE 05. HIGH BARGAINING POWER OF BUYERS
  • FIGURE 06. HIGH THREAT OF SUBSTITUTES
  • FIGURE 07. HIGH THREAT OF NEW ENTRANTS
  • FIGURE 08. MODERATE INTENSITY OF RIVALRY
  • FIGURE 09. DRIVERS, RESTRAINTS AND OPPORTUNITIES: GLOBALURETEROSCOPY MARKET
  • FIGURE 10. URETEROSCOPY MARKET, BY PRODUCT, 2021(%)
  • FIGURE 11. COMPARATIVE SHARE ANALYSIS OF URETEROSCOPY MARKET FOR FLEXIBLE URETEROSCOPE, BY COUNTRY 2021-2031(%)
  • FIGURE 12. COMPARATIVE SHARE ANALYSIS OF URETEROSCOPY MARKET FOR SEMI- RIGID URETEROSCOPE, BY COUNTRY 2021-2031(%)
  • FIGURE 13. URETEROSCOPY MARKET, BY APPLICATION, 2021(%)
  • FIGURE 14. COMPARATIVE SHARE ANALYSIS OF URETEROSCOPY MARKET FOR UROLITHIASIS, BY COUNTRY 2021-2031(%)
  • FIGURE 15. COMPARATIVE SHARE ANALYSIS OF URETEROSCOPY MARKET FOR KIDNEY CANCER, BY COUNTRY 2021-2031(%)
  • FIGURE 16. COMPARATIVE SHARE ANALYSIS OF URETEROSCOPY MARKET FOR URINARY STRICTURE, BY COUNTRY 2021-2031(%)
  • FIGURE 17. COMPARATIVE SHARE ANALYSIS OF URETEROSCOPY MARKET FOR OTHERS, BY COUNTRY 2021-2031(%)
  • FIGURE 18. URETEROSCOPY MARKET, BY END USER, 2021(%)
  • FIGURE 19. COMPARATIVE SHARE ANALYSIS OF URETEROSCOPY MARKET FOR HOSPITALS, BY COUNTRY 2021-2031(%)
  • FIGURE 20. COMPARATIVE SHARE ANALYSIS OF URETEROSCOPY MARKET FOR AMBULATORY SURGICAL CENTERS, BY COUNTRY 2021-2031(%)
  • FIGURE 21. COMPARATIVE SHARE ANALYSIS OF URETEROSCOPY MARKET FOR OTHERS, BY COUNTRY 2021-2031(%)
  • FIGURE 22. URETEROSCOPY MARKET BY REGION, 2021
  • FIGURE 23. U.S. URETEROSCOPY MARKET, 2021-2031 ($MILLION)
  • FIGURE 24. CANADA URETEROSCOPY MARKET, 2021-2031 ($MILLION)
  • FIGURE 25. MEXICO URETEROSCOPY MARKET, 2021-2031 ($MILLION)
  • FIGURE 26. GERMANY URETEROSCOPY MARKET, 2021-2031 ($MILLION)
  • FIGURE 27. FRANCE URETEROSCOPY MARKET, 2021-2031 ($MILLION)
  • FIGURE 28. UK URETEROSCOPY MARKET, 2021-2031 ($MILLION)
  • FIGURE 29. ITALY URETEROSCOPY MARKET, 2021-2031 ($MILLION)
  • FIGURE 30. SPAIN URETEROSCOPY MARKET, 2021-2031 ($MILLION)
  • FIGURE 31. REST OF EUROPE URETEROSCOPY MARKET, 2021-2031 ($MILLION)
  • FIGURE 32. JAPAN URETEROSCOPY MARKET, 2021-2031 ($MILLION)
  • FIGURE 33. CHINA URETEROSCOPY MARKET, 2021-2031 ($MILLION)
  • FIGURE 34. AUSTRALIA URETEROSCOPY MARKET, 2021-2031 ($MILLION)
  • FIGURE 35. INDIA URETEROSCOPY MARKET, 2021-2031 ($MILLION)
  • FIGURE 36. SOUTH KOREA URETEROSCOPY MARKET, 2021-2031 ($MILLION)
  • FIGURE 37. REST OF ASIA-PACIFIC URETEROSCOPY MARKET, 2021-2031 ($MILLION)
  • FIGURE 38. BRAZIL URETEROSCOPY MARKET, 2021-2031 ($MILLION)
  • FIGURE 39. SAUDI ARABIA URETEROSCOPY MARKET, 2021-2031 ($MILLION)
  • FIGURE 40. SOUTH AFRICA URETEROSCOPY MARKET, 2021-2031 ($MILLION)
  • FIGURE 41. REST OF LAMEA URETEROSCOPY MARKET, 2021-2031 ($MILLION)
  • FIGURE 42. TOP WINNING STRATEGIES, BY YEAR
  • FIGURE 43. TOP WINNING STRATEGIES, BY DEVELOPMENT
  • FIGURE 44. TOP WINNING STRATEGIES, BY COMPANY
  • FIGURE 45. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 46. COMPETITIVE DASHBOARD
  • FIGURE 47. COMPETITIVE HEATMAP: URETEROSCOPY MARKET
  • FIGURE 48. TOP PLAYER POSITIONING, 2021
  • FIGURE 49. BOSTON SCIENTIFIC CORPORATION: NET SALES, 2019-2021 ($MILLION)
  • FIGURE 50. BOSTON SCIENTIFIC CORPORATION: REVENUE SHARE BY SEGMENT, 2021 (%)
  • FIGURE 51. BOSTON SCIENTIFIC CORPORATION: REVENUE SHARE BY REGION, 2021 (%)
  • FIGURE 52. OLYMPUS CORPORATION: NET REVENUE, 2019-2021 ($MILLION)
  • FIGURE 53. OLYMPUS CORPORATION: REVENUE SHARE BY SEGMENT, 2021 (%)
  • FIGURE 54. OLYMPUS CORPORATION: REVENUE SHARE BY REGION, 2021 (%)
  • FIGURE 55. HOYA CORPORATION: NET REVENUE, 2019-2021 ($MILLION)
  • FIGURE 56. HOYA CORPORATION: REVENUE SHARE BY SEGMENT, 2021 (%)
  • FIGURE 57. STERIS PLC: NET SALES, 2019-2021 ($MILLION)
  • FIGURE 58. STERIS PLC: REVENUE SHARE BY SEGMENT, 2021 (%)
  • FIGURE 59. STERIS PLC: REVENUE SHARE BY REGION, 2021 (%)
  • FIGURE 60. STRYKER CORPORATION: NET REVENUE, 2019-2021 ($MILLION)
  • FIGURE 61. STRYKER CORPORATION: REVENUE SHARE BY SEGMENT, 2021 (%)
  • FIGURE 62. STRYKER CORPORATION: REVENUE SHARE BY REGION, 2021 (%)